Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaad.2016.07.066 | DOI Listing |
Publication Analysis
Top Keywords
reply "re
4
"re comorbid
4
comorbid autoimmune
4
autoimmune diseases
4
diseases patients
4
patients vitiligo
4
vitiligo cross-sectional
4
cross-sectional study"
4
reply
1
comorbid
1
Similar Publications
Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease".
Ophthalmic Plast Reconstr Surg
January 2025
Reply to Aravindh Rathinam, Jonathan Katz, Robert Marcovich, and Hemendra N. Shah's Letter to the Editor re: Michael Baboudjian, Hashim Hashim, Nikita Bhatt, et al. Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms. Eur Urol 2024;86:213-20.
Eur Urol
December 2024
Department of Urology, CHU Hôpitaux de Rouen-Hôpital Charles Nicolle, Rouen, France.
Reply to Giuseppe Reitano, Filippo Carletti, and Fabio Zattoni's Letter to the Editor re: Evelien J.E. van Altena, Bernard H.E. Jansen, Marieke L. Korbee, et al. Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.09.015.
Eur Urol Oncol
December 2024
Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Prostate Cancer Network Amsterdam, Amsterdam, The Netherlands.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!